We recently demonstrated that the increased density of CD8(+)TCF1(+) T cells in the tumor center is an independent prognostic biomarker linked with improved DFS only in TNBC but not in luminal type A breast cancer patients [24], showing the importance of providing a functional insight into CD8(+) cells rather than merely counting their numbers. Here, CD8A is linked to breast cancer.